Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR - Concepedia

Concepedia

Publication | Closed Access

Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR

15

Citations

0

References

2005

Year

Larry K. Kvols, Kjell Öberg, WW de Herder, Lowell Anthony, J. E. Glusman, Ly-Le Tran, Bertram Wiedenmann

Journal of Clinical Oncology

Abstract

8024